Amylyx Pharmaceuticals CFO James M. Frates Sells $1.21M of Stock
James M. Frates, CFO, sold 40,000 shares of Amylyx Pharmaceuticals, Inc. at $29.39 to $30.97 a share (average $30.19) in 4 transactions, worth $1.21M in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 233,625 (-3.0%).
Amylyx Pharmaceuticals Co-CEO Joshua B. Cohen Sells $2.98M of Stock
Joshua B. Cohen, Co-CEO, sold 100,000 shares of Amylyx Pharmaceuticals, Inc. at $29.39 to $30.11 a share (average $29.84) in 2 transactions, worth $2.98M in total on Nov 9, 2026. Shares held after the trade: 3,513,123 (-1.7%).
Amylyx Pharmaceuticals Co-CEO Justin B. Klee Sells $2.98M of Stock
Justin B. Klee, Co-CEO, sold 100,000 shares of Amylyx Pharmaceuticals, Inc. at $29.39 to $30.11 a share (average $29.84) in 2 transactions, worth $2.98M in total on Nov 9, 2026. Shares held after the trade: 3,513,056 (-1.7%).
Amylyx Pharmaceuticals Director George M. Milne Jr. Sells $831K of Stock
George M. Milne Jr., Director, sold 30,000 shares of Amylyx Pharmaceuticals, Inc. at $27.70 a share, worth $831K in total on Oct 5, 2026. Shares held after the trade: 782,881 (-3.7%).
Amylyx Pharmaceuticals CFO James M. Frates Sells $350K of Stock
James M. Frates, CFO, sold 10,810 shares of Amylyx Pharmaceuticals, Inc. at $32.27 to $33.23 a share (average $32.36) in 2 transactions, worth $350K in total on Sep 10, 2026. Shares held after the trade: 233,625 (-0.4%).
Amylyx Pharmaceuticals CMO Camille L. Bedrosian Sells $325K of Stock
Camille L. Bedrosian, CMO, sold 10,028 shares of Amylyx Pharmaceuticals, Inc. at $32.21 to $33.09 a share (average $32.40) in 2 transactions, worth $325K in total on Sep 10, 2026. Shares held after the trade: 278,064 (-0.7%).
Amylyx Pharmaceuticals Co-CEO Justin B. Klee Sells $980K of Stock
Justin B. Klee, Co-CEO, sold 30,464 shares of Amylyx Pharmaceuticals, Inc. at $32.13 to $33.16 a share (average $32.18) in 2 transactions, worth $980K in total on Sep 10, 2026. Shares held after the trade: 3,613,056 (-0.0%).
Amylyx Pharmaceuticals Co-CEO Joshua B. Cohen Sells $981K of Stock
Joshua B. Cohen, Co-CEO, sold 30,464 shares of Amylyx Pharmaceuticals, Inc. at $32.16 to $33.15 a share (average $32.19) in 2 transactions, worth $981K in total on Sep 10, 2026. Shares held after the trade: 3,613,123 (-0.0%).
Amylyx Pharmaceuticals CLO Gina Mazzariello Sells $309K of Stock
Gina Mazzariello, CLO, sold 9,525 shares of Amylyx Pharmaceuticals, Inc. at $32.46 a share, worth $309K in total on Sep 10, 2026. Shares held after the trade: 190,849 (-4.8%).